Top Markets
Coin of the day
Origin Therapeutics Holdings Inc. Origin Therapeutics Holdings Inc.

Origin Therapeutics Holdings Inc.

ORIG
Rank in Stocks #38340
Origin Therapeutics Holdings Inc. functions as an investment firm,... Origin Therapeutics Holdings Inc. functions as an investment firm, predominantly focusing its efforts on the burgeoning psychedelic industry within Canada. Its strategic intent is to finance various stages of development, including scientific research, product conceptualization, manufacturing, quality control, market penetration, and sales of psychedelic substances, alongside any related endeavors. Incorporated in 2020, the company, originally known as 1278700 B.C. Ltd., maintains its main office in Vancouver, Canada.
Share Price
$0.01851783
Last synced: 2023-05-23
Market Cap
$1.05M
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
CA
Trade Origin Therapeutics Holdings Inc. (ORIG)

Category

P/B ratio for Origin Therapeutics Holdings Inc. (ORIG)
P/B ratio as of 2026 TTM: 0
According to Origin Therapeutics Holdings Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Origin Therapeutics Holdings Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors